InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.55
(
-0.19%
)
US TECH 100
19,287.60
(
-0.24%
)
Dow Jones
42,063.36
(
0.09%
)
Brent Oil
74.44
(
0.74%
)
Bitcoin
64,362.47
(
1.16%
)
Post# of 253175
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

RNsidersbuying

Send PM Follow Ignore
Followers 46
Posts 4547
Boards Moderated 0
Alias Born 07/26/2010

RNsidersbuying

Re: 57_2001 post# 234772

Saturday, 09/26/2020 12:05:02 PM

Saturday, September 26, 2020 12:05:02 PM

Post# of 253175
HGEN 9.77 - interesting. How many other SEC-compliant-stocks do we know of that have a covid-therapeutic in Phase 3?

Humanigen expects to complete the targeted enrollment of 300 patients this month with topline data available in the fourth quarter.

https://www.humanigen.com/press/Humanigen-Announces-Review-of-Lenzilumab-Phase-3-Study-in-COVID-19-by-Data-Safety-Monitoring-Board
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up